0001209191-23-055446.txt : 20231116
0001209191-23-055446.hdr.sgml : 20231116
20231116073521
ACCESSION NUMBER: 0001209191-23-055446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231115
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bergwerk Dov
CENTRAL INDEX KEY: 0001997381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 231412421
MAIL ADDRESS:
STREET 1: C/O TEVA
STREET 2: 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-15
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001997381
Bergwerk Dov
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.,
124 DVORA HANEVI'A STREET
TEL AVIV
L3
6944020
ISRAEL
0
1
0
0
Acting Chief Legal Officer
0
Restricted Share Units
2023-11-15
4
A
0
33482
0.00
A
Ordinary Shares
33482
33482
D
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources
and Compensation Committee, the cash value of one ordinary share.
Restricted share units were granted on November 15, 2023, with 8,370 vesting on each of November 15, 2024, November 15, 2025 and November 15, 2026, and 8,372 vesting on November 15, 2027.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
/s/ Dov Bergwerk
2023-11-16